GLP-1 medications are a newer treatment option for certain patients with obstructive sleep apnea (OSA), particularly those who are overweight or obese. Originally developed to help manage diabetes and support weight loss, these medications have been shown to reduce the severity of sleep apnea by addressing one of its most significant underlying risk factors: excess body weight.
Research has demonstrated that meaningful weight loss achieved with GLP-1 therapy can lead to fewer breathing interruptions during sleep, improved oxygen levels, reduced daytime sleepiness, and better overall sleep quality.
GLP-1 medications work by mimicking hormones that help regulate appetite, slow stomach emptying, and increase feelings of fullness. As patients lose weight, excess tissue around the upper airway may decrease, helping to reduce airway obstruction during sleep.
In clinical studies, patients treated with GLP-1 therapy experienced significant reductions in apnea-hypopnea index (AHI), a key measure used to assess the severity of obstructive sleep apnea. By targeting weight-related contributors to OSA, GLP-1 therapy can help improve both sleep health and overall cardiometabolic health.
GLP-1 therapy may be appropriate for adults with obstructive sleep apnea who are overweight or obese and are looking for additional treatment options beyond traditional therapies. You may be a candidate if you:
A comprehensive evaluation can help determine whether GLP-1 therapy is appropriate based on your health history, sleep apnea severity, and treatment goals.
GLP-1 therapy is typically part of a long-term treatment strategy that includes ongoing medical supervision, lifestyle modifications, and regular follow-up visits. Weight loss occurs gradually over time, and improvements in sleep apnea symptoms may develop as weight decreases.
Many patients experience benefits that extend beyond sleep, including improvements in blood pressure, blood sugar control, cardiovascular risk factors, energy levels, and overall quality of life. Your care team will monitor your progress and adjust treatment recommendations as needed to help you achieve the best possible outcomes.
Obstructive sleep apnea is closely connected to cardiovascular, pulmonary, metabolic, and vascular health. At Deborah Heart and Lung Center, our sleep specialists work alongside experts in cardiology, pulmonary medicine, vascular medicine, and weight management to develop personalized treatment plans that address the root causes of sleep apnea.
This integrated approach allows us to evaluate how sleep apnea affects the entire body — not just sleep quality — and helps ensure patients receive comprehensive care designed to improve both sleep health and long-term wellness.
Pulmonologist Carol Ash, DO, explains how GLP-1 medications like tirzepatide support weight loss and can help improve or even reverse obstructive sleep apnea by reducing excess tissue that narrows the airway during sleep.
Watch VideoBy participating in this quiz, or screening or health assessment, I recognize and accept all risks associated with it. I understand that the program will only screen for certain risk factors and does not constitute a complete physical exam. For the diagnosis of a medical problem, I must see a physician for a complete medical exam. I release Deborah Heart and Lung Center and any other organization(s) involved in this screening, and their employees and agents, from all liabilities, medical claims or expenses which may arise from my participation. Thank you for investing in your health by participating today.